New Study: Ketogenic Diet Without Chemo or Radiation for Control of Mutant Glioblastoma

SHR # 2731:: New Study: Ketogenic Diet Without Chemo or Radiation for Control of Mutant Glioblastoma - Prof. Thomas Seyfried, Ph.D. - Successful treatment of glioblastoma (GBM) remains futile despite decades of intense research. GBM is similar to most other malignant cancers in requiring glucose and glutamine for growth, regardless of histological or genetic heterogeneity. Ketogenic metabolic therapy (KMT) is a non-toxic nutritional intervention for cancer management. We report the case of a 32-year-old man who presented in 2014 with seizures and a right frontal lobe tumor on MRI. The long-term survival of this patient, now at 80 months, could be due in part to a therapeutic metabolic synergy between KMT and the IDH1 mutation that simultaneously target the glycolysis and glutaminolysis pathways that are essential for GBM growth. Get the book Cancer As A Metabolic Disease today at http://shrnetwork.biz/cancer-metabolic